Okairos AG

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Tonix Li

Three European biotech companies have formed a strategic collaboration for the development and large-scale manufacture of a novel adenoviral vector-based vaccine targeting the SARS-CoV-2 spike protein

Despite being a relatively new player to cancer research, Boehringer Ingelheim GMBH is hoping that the acquisition of Austria's ViraTherapeutics GMBH will push it to the forefront in terms of the

Boehringer Ingelheim GMBH has more than doubled the size of its corporate venture capital fund from €100m to €250m ($301.8m) to expand its US footprint and investment focus, while continuing to fund